Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Single Arm Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent WHO Grade III Malignant Astrocytoma

NCT03450850 is registered in ClinicalTrials.gov with Daniela A. Bota as lead sponsor.

NCT NCT03450850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03450850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Single Arm Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent WHO Grade III Malignant Astrocytoma
Lead sponsor
Daniela A. Bota
Phase
Not applicable
Overall status
Completed
Start date
May 21, 2020
Completion date
August 7, 2025
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, grade iii